EUVIMEDEUVIMED entdecken
Crossref

Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage

Yu Zhang iD, Chui Mei Ong, Kara Lynch iD, Javier Waksman, Alan H B Wu

Laboratory Medicine · 2024

DOI: 10.1093/labmed/lmae022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Yu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas MD Anderson Cancer Center Division of Pathology and Laboratory Medicine, Houston, TX, US. Hauptthemen laut MEDLINE: MicroRNAs, Chemical and Drug Induced Liver Injury, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serum level of microRNA-122 (miR-122) has been reported as a sensitive diagnostic biomarker for detecting liver injury, comparable to the aminotransferases. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities are increased in other conditions, such as acute skeletal muscle injury (ASMI). We determined whether miR-122 is nonspecifically increased in patients suffering from ASMI.

Methods

We measured ALT, AST, creatine kinase (CK), and miR-122 in 3 groups: healthy controls (n = 24), patients with ASMI (total n = 29, 11 with recreational drug use and 18 without recreational drug use), and patients with acute liver injury (ALI; n = 14).

Results

Levels of ALT, AST, and CK increased 83%, 97%, and 100% for patients with ASMI and 100% for all 3 enzymes in ALI patients. In contrast, miR-122 increased in 34% of patients with ASMI (44.4% with recreational drug use and 18.2% without recreational drug use) and 100% of ALI patients. In 2 drug-induced liver injury cases, miR-122 increased about 12-24 hours before ALT and AST.

Conclusion

Recreational drug misuse is associated with both rhabdomyolysis and drug-induced liver injury (DILI). The traditional liver function markers AST and ALT were nonspecifically increased in the majority of patients with ASMI. miR-122 is only increased in patients at risk for DILI and demonstrates superior specificity for liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsChemical and Drug Induced Liver InjuryBiomarkersHumansMaleAdultFemaleMiddle AgedAspartate AminotransferasesAlanine TransaminaseMuscle, SkeletalCreatine KinaseYoung Adult

Stichwörter der Autor:innen

acute liver injuryacute skeletal muscle injurybiomarkermiR-122

Substanzen

MIRN122 microRNA, humanMicroRNAsBiomarkersAspartate AminotransferasesAlanine TransaminaseCreatine Kinase

Autor:innen und Institutionen

  • University of Texas MD Anderson Cancer Center Division of Pathology and Laboratory Medicine, Houston, TX, US.
  • University of California San Francisco - Laboratory Medicine, San Francisco, CA, US.
  • Department of Medicine, University of California San Francisco, San Francisco, CA, US.
  • University of California San Francisco Medical Center at Parnassus - Laboratory Medicine, San Francisco, CA, US.

ORCID-Profile: Yu Zhang, Kara Lynch

Zitieren

APA

Zhang, Y., Ong, C. M., Lynch, K., Waksman, J., & Wu, A. H. B. (2024). Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage. Laboratory Medicine. https://doi.org/10.1093/labmed/lmae022

Vancouver

Zhang Y, Ong CM, Lynch K, Waksman J, Wu AHB. Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage. Laboratory Medicine. 2024. doi:10.1093/labmed/lmae022

BibTeX
@article{Zhang2024,
  author = {Zhang, Yu and Ong, Chui Mei and Lynch, Kara and Waksman, Javier and Wu, Alan H B},
  title = {Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage},
  journal = {Laboratory Medicine},
  year = {2024},
  doi = {10.1093/labmed/lmae022}
}
Kostenlos starten →